Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Benzoyl peroxide 4% w/w Cream, skin Stiefel Laboratories PTE Limited, Jurong, Singapore Brevoxyl Ibutilide fumarate 0.1 mg/mL in 10 mL Solution, infusion, vial Pharmacia & Upjohn Company, Kalamazoo, Michigan, United States of America Corvert Atorvastatin calcium 10 mg, 20 mg, 40 mg Tablets, film coated Godecke AG., Freiburg, Germany and Warner Lambert Company, Lititz, Pennsylvania, United States of America Lipitor Sodium fluoride 2.73% w/v Paste, topical Pascal Company Inc., Bellevue, Washington, United States of America Radent Prophy Paste (cherry flavour) Sodium fluoride 2.73% w/v Paste, topical Pascal Company Inc., Bellevue, Washington, United States of America Radent Prophy Paste (mint flavour) Dated this 19th day of August 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.